- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- February 2024
- 135 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- November 2021
- 131 Pages
Global
From €13647EUR$14,995USD£11,699GBP
- Report
- January 2024
- 93 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Imitrex (sumatriptan) is a prescription medication used to treat migraine headaches. It belongs to a class of drugs known as triptans, which are used to treat moderate to severe migraine pain. Imitrex works by narrowing blood vessels around the brain, reducing inflammation and relieving pain. It is available in tablet, nasal spray, and injection forms. Imitrex is often used in combination with other medications, such as non-steroidal anti-inflammatory drugs (NSAIDs) and anti-nausea medications.
Imitrex is part of the larger analgesic market, which includes medications used to treat pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, and arthritis. They are available in a variety of forms, including over-the-counter medications, prescription medications, and natural remedies.
Some companies in the Imitrex market include GlaxoSmithKline, Teva Pharmaceuticals, and Mylan. Show Less Read more